Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL BIOTIDOTE : revenue, balance sheet and financial ratios

SELARL BIOTIDOTE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75009), this company of category PME shows in 2023 a net income negative of -54 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL BIOTIDOTE (SIREN 522393420)
Indicator 2023 2022 2021 2020 2019 2017
Revenue N/C N/C N/C N/C N/C N/C
Net income -53 934 € 61 672 € 62 408 € 26 617 € -18 886 € 19 192 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, SELARL BIOTIDOTE records a net loss of 54 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-53 934 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

114.62%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

36.258%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

88.7%

Solvency indicators evolution
SELARL BIOTIDOTE

Sector positioning

Debt ratio
114.62 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average +37 pts over 3 years

In 2023, the debt ratio of SELARL BIOTIDOTE (114.62) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
36.26% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average -41 pts over 3 years

In 2023, the financial autonomy of SELARL BIOTIDOTE (36.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 144.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

144.414

Liquidity indicators evolution
SELARL BIOTIDOTE

Sector positioning

Liquidity ratio
144.41 2023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Average -19 pts over 3 years

In 2023, the liquidity ratio of SELARL BIOTIDOTE (144.41) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL BIOTIDOTE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL BIOTIDOTE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL BIOTIDOTE

What is the revenue of SELARL BIOTIDOTE ?

The revenue of SELARL BIOTIDOTE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL BIOTIDOTE profitable?

SELARL BIOTIDOTE recorded a net loss in 2023.

Where is the headquarters of SELARL BIOTIDOTE ?

The headquarters of SELARL BIOTIDOTE is located in PARIS (75009), in the department Paris.

Where to find the tax return of SELARL BIOTIDOTE ?

The tax return of SELARL BIOTIDOTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL BIOTIDOTE operate?

SELARL BIOTIDOTE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.